Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Zevra Therapeutics, Inc. ZVRA

Full chart Compare
Set alert

Price alert · ZVRA

All alert types
10.26 USD +0.16 (+1.58%)

At closeNov 3, 2026, 4:00 PM EST

10.68 +0.42 +4.09%

After hours · Nov 3, 4:00 PM ET

10.04 Day range 10.42
8.01 52-week range 15.04
YTD
+14.51%
1 year
+0.49%

Financial health

Altman Z-Score

5.35 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 3
  • P/B 2

Valuation

P/E 6.4×
FY 2016: -2.6×FY 2017: -1.4×FY 2018: -0.6×FY 2019: -0.5×FY 2020: -3.5×FY 2021: -4.1×FY 2022: -5.9×FY 2023: -5.0×FY 2024: -3.7×FY 2025: 6.4×
FY 2016 5y median -4.1× FY 2025
P/S 4.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.9×FY 2020: 3.4×FY 2021: 9.0×FY 2022: 15.6×FY 2023: 8.5×FY 2024: 16.3×FY 2025: 4.7×
FY 2016 5y median 9.0× FY 2025
P/B 3.2×
FY 2016: -2.3×FY 2017: -1.0×FY 2018: -0.5×FY 2019: -0.2×FY 2020: -0.7×FY 2021: 2.0×FY 2022: 2.1×FY 2023: 3.8×FY 2024: 9.7×FY 2025: 3.2×
FY 2016 5y median 3.2× FY 2025
P/FCF -204×
FY 2016: -1.4×FY 2017: -1.8×FY 2018: -0.6×FY 2019: -0.5×FY 2020: -22.6×FY 2021: 25.1×FY 2022: -8.4×FY 2023: -6.9×FY 2024: -5.5×FY 2025: -204×
FY 2016 5y median -6.9× FY 2025
EV/EBITDA 5.0×
FY 2016: -3.4×FY 2017: -4.3×FY 2018: -1.8×FY 2019: -4.9×FY 2020: -20.4×FY 2021: -18.8×FY 2022: -4.4×FY 2023: -5.3×FY 2024: -5.4×FY 2025: 5.0×
FY 2016 5y median -5.3× FY 2025
EV/Sales 4.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 6.8×FY 2020: 8.3×FY 2021: 5.2×FY 2022: 11.0×FY 2023: 8.5×FY 2024: 17.5×FY 2025: 4.7×
FY 2016 5y median 8.5× FY 2025
FCF Yield -0.5%
FY 2016: -70.6%FY 2017: -56.1%FY 2018: -169.9%FY 2019: -211.4%FY 2020: -4.4%FY 2021: 4.0%FY 2022: -11.9%FY 2023: -14.6%FY 2024: -18.1%FY 2025: -0.5%
FY 2016 5y median -11.9% FY 2025

Profitability

Gross Margin 84.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 77.1%FY 2020: 90.2%FY 2021: 92.8%FY 2022: 97.8%FY 2023: 89.3%FY 2024: 68.6%FY 2025: 84.5%
FY 2016 5y median 89.3% FY 2025
Operating Margin -4.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -158.4%FY 2020: -42.2%FY 2021: 27.0%FY 2022: -418.9%FY 2023: -180.6%FY 2024: -368.5%FY 2025: -4.0%
FY 2016 5y median -180.6% FY 2025
Net Margin 78.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -191.0%FY 2020: -96.0%FY 2021: -29.9%FY 2022: -263.5%FY 2023: -167.7%FY 2024: -446.9%FY 2025: 78.2%
FY 2016 5y median -167.7% FY 2025
ROE 53.8%
FY 2016: 88.3%FY 2017: 75.4%FY 2018: 84.8%FY 2019: 32.9%FY 2020: 19.2%FY 2021: -6.7%FY 2022: -35.6%FY 2023: -74.4%FY 2024: -266.0%FY 2025: 53.8%
FY 2016 5y median -35.6% FY 2025
ROIC -1.7%
FY 2016: -47.8%FY 2017: -75.0%FY 2018: -305.0%FY 2019: -379.1%FY 2020: -122.6%FY 2021: 6.0%FY 2022: -39.2%FY 2023: -36.2%FY 2024: -60.2%FY 2025: -1.7%
FY 2016 5y median -36.2% FY 2025
ROA 29.2%
FY 2016: -19.5%FY 2017: -82.7%FY 2018: -211.1%FY 2019: -233.4%FY 2020: -113.8%FY 2021: -6.4%FY 2022: -23.2%FY 2023: -26.7%FY 2024: -59.2%FY 2025: 29.2%
FY 2016 5y median -23.2% FY 2025

Growth (YoY)

Revenue 350.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 3.5%FY 2021: 115.6%FY 2022: -64.5%FY 2023: 170.3%FY 2024: -14.0%FY 2025: 350.9%
FY 2016 FY 2025
Operating Income 95.1%
FY 2016: -64.3%FY 2017: 11.0%FY 2018: -67.5%FY 2019: 63.6%FY 2020: 72.4%FY 2021: 237.8%FY 2022: -650.7%FY 2023: -16.5%FY 2024: -75.4%FY 2025: 95.1%
FY 2016 FY 2025
EPS (diluted) 159.2%
FY 2016: 84.8%FY 2017: -161.7%FY 2018: -6.4%FY 2019: 73.7%FY 2020: 75.7%FY 2021: 34.3%FY 2022: 63.0%FY 2023: -66.7%FY 2024: -75.4%FY 2025: 159.2%
FY 2016 FY 2025
Free Cash Flow 96.5%
FY 2016: -49.1%FY 2017: -9.4%FY 2018: -62.9%FY 2019: 56.2%FY 2020: 91.7%FY 2021: 624.2%FY 2022: -282.0%FY 2023: -79.9%FY 2024: -105.9%FY 2025: 96.5%
FY 2016 FY 2025

Financial Health

Current Ratio 5.7×
FY 2016: 11.2×FY 2017: 4.0×FY 2018: 2.0×FY 2019: 1.3×FY 2020: 1.1×FY 2021: 27.2×FY 2022: 7.7×FY 2023: 1.2×FY 2024: 2.5×FY 2025: 5.7×
FY 2016 5y median 5.7× FY 2025
Quick Ratio 5.6×
FY 2016: 11.0×FY 2017: 4.0×FY 2018: 2.0×FY 2019: 1.3×FY 2020: 1.1×FY 2021: 27.2×FY 2022: 7.7×FY 2023: 0.9×FY 2024: 2.5×FY 2025: 5.6×
FY 2016 5y median 5.6× FY 2025
Debt / Equity 0.4×
FY 2016: -4.9×FY 2017: -1.6×FY 2018: -1.2×FY 2019: -1.1×FY 2020: -1.1×FY 2021: 0.0×FY 2022: 0.2×FY 2023: 0.7×FY 2024: 1.5×FY 2025: 0.4×
FY 2016 5y median 0.4× FY 2025
Net Debt / EBITDA 0.0×
FY 2016: -2.2×FY 2017: -2.5×FY 2018: -1.2×FY 2019: -4.3×FY 2020: -12.2×FY 2021: 14.0×FY 2022: 1.8×FY 2023: -0.0×FY 2024: -0.3×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Interest Coverage -0.5×
FY 2016: -5.3×FY 2017: -4.5×FY 2018: -7.9×FY 2019: -3.1×FY 2020: -0.8×FY 2021: 20.6×FY 2022: -127×FY 2023: -33.0×FY 2024: -11.8×FY 2025: -0.5×
FY 2016 5y median -11.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31